Magnetic resonance imaging characteristics of molecular subgroups in pediatric H3 K27M mutant diffuse midline glioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Clinical Neuroradiology, 32, S. 249-258
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2021
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Springer Science and Business Media LLC
- (wann)
-
2021
- Urheber
-
Hohm, Annika
Karremann, Michael
Gielen, Gerrit H.
Pietsch, Torsten
Warmuth-Metz, Monika
Vandergrift, Lindsey A.
Bison, Brigitte
Stock, Annika
Hoffmann, Marion
Pham, Mirko
Kramm, Christof M.
Nowak, Johannes
- DOI
-
10.1007/s00062-021-01120-3
- URN
-
urn:nbn:de:bvb:384-opus4-917370
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hohm, Annika
- Karremann, Michael
- Gielen, Gerrit H.
- Pietsch, Torsten
- Warmuth-Metz, Monika
- Vandergrift, Lindsey A.
- Bison, Brigitte
- Stock, Annika
- Hoffmann, Marion
- Pham, Mirko
- Kramm, Christof M.
- Nowak, Johannes
- Universität Augsburg
- Springer Science and Business Media LLC
Entstanden
- 2021
Ähnliche Objekte (12)
Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO‐grade II: report from the German/Swiss SIOP‐LGG 2004 cohort
HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]
Natural history of pediatric low-grade glioma disease - first multi-state model analysis
Integrative genomics identifies biological subgroups, molecular markers, and novel therapeutic targets in pediatric brain tumors
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Neurosurgical morbidity in pediatric supratentorial midline low‐grade glioma: results from the German LGG studies
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Identification and characterization of adaptive immune responses to H3K27M peptide vaccination in diffuse midline glioma
Chemotherapy and diffuse low-grade gliomas : a survey within the European Low-Grade Glioma Network
Identification of new therapeutic targets for diffuse intrinsic pontine glioma using large-scale RNAi screening
Diffuse Mittelliniengliome, H3 K27M-mutiert sind im Vergleich zu Glioblastomen, H3 K27M-Wildtyp von Mittellinienstrukturen mit einem geringeren perifokalen Ödem und Kontrastmittelaufnahme assoziiert : = Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M wildtype of midline structures
Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO‐grade II: report from the German/Swiss SIOP‐LGG 2004 cohort
HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]
Natural history of pediatric low-grade glioma disease - first multi-state model analysis
Integrative genomics identifies biological subgroups, molecular markers, and novel therapeutic targets in pediatric brain tumors
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Neurosurgical morbidity in pediatric supratentorial midline low‐grade glioma: results from the German LGG studies
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Identification and characterization of adaptive immune responses to H3K27M peptide vaccination in diffuse midline glioma
Chemotherapy and diffuse low-grade gliomas : a survey within the European Low-Grade Glioma Network
Identification of new therapeutic targets for diffuse intrinsic pontine glioma using large-scale RNAi screening
Diffuse Mittelliniengliome, H3 K27M-mutiert sind im Vergleich zu Glioblastomen, H3 K27M-Wildtyp von Mittellinienstrukturen mit einem geringeren perifokalen Ödem und Kontrastmittelaufnahme assoziiert : = Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M wildtype of midline structures
Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO‐grade II: report from the German/Swiss SIOP‐LGG 2004 cohort
HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]
Natural history of pediatric low-grade glioma disease - first multi-state model analysis
Integrative genomics identifies biological subgroups, molecular markers, and novel therapeutic targets in pediatric brain tumors
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Neurosurgical morbidity in pediatric supratentorial midline low‐grade glioma: results from the German LGG studies
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Identification and characterization of adaptive immune responses to H3K27M peptide vaccination in diffuse midline glioma
Chemotherapy and diffuse low-grade gliomas : a survey within the European Low-Grade Glioma Network
Identification of new therapeutic targets for diffuse intrinsic pontine glioma using large-scale RNAi screening